CRISPR technology, driven by Cas9, redefines gene editing, facilitating targeted DNA modifications that advance genetic ...

After months of planning and a grueling five-day installation process, Lab to Landscape is ready to showcase the marriage of ...

Take CRISPR Therapeutics (NASDAQ: CRSP) and Intellia Therapeutics (NASDAQ: NTLA), two biotechs specializing in gene editing. Finance, is $83.60; the latter earns a price target of $50.80 from ...

There is huge unmet need for new rare disease therapies, where patients have few or no available options. According to the ...

Zhang is one of 12 students who recently returned from an intensive, three-week experience organized and led by Industrial ...

Mr Trump thinks he can pursue the national interest more effectively through hyperactive transactions. Everything is up for ...

Scribe Therapeutics Inc. (Scribe), a genetic medicines company unlocking the potential of CRISPR to transform human health, today announced its participation in the following conferences: Keystone ...

Reported promising safety and preliminary efficacy data for REC-617, an oral CDK7 inhibitor, and met primary endpoints and ...